In summary, cervical cancer progression is marked by a dynamic modulation of claudins – with early lesions showing claudin overexpression and late-stage cancers showing claudin loss (for CLDN1,2,4,7), alongside sustained or newfound expression of other claudins (CLDN6,8,9) that promote metastasis. Here, CLDN6 is linked to cervical carcinoma.